GSK's consumer arm draws private equity interest - Bloomberg News - NewsBreak
#gsk
#bloombergnews
2 years ago By Vivian — Oct 12 (Reuters) - GlaxoSmithKline's consumer healthcare unit is drawing interest from private equity firms such as Advent, CVC and KKR, ahead of the Briti
Activist investor Bluebell takes stake in GSK - FT - NewsBreak
#activist
#bluebell
#gsk
#ft
3 years ago By Poppy — Sept 22 (Reuters) - Activist investor Bluebell Capital Partners has taken a small stake in British pharmaceuticals group GlaxoSmithKline in efforts to shak
GlaxoSmithKline’s (GSK) “Buy” Rating Reaffirmed at The Goldman Sachs Group
#glaxosmithkline
#gsk
#buy
3 years ago By Gomez — The Goldman Sachs Group restated their buy rating on shares of GlaxoSmithKline (LON:GSK) in a research note released on Thursday morning, Price Targets.com
Vaxcyte asks chairman Slaoui to step down after GSK harassment claim
#vaxcyte
#slaoui
#gsk
3 years ago By Alvarez — U.S. vaccine developer Vaxcyte Inc said on Thursday chairman Moncef Slaoui has agreed to step down, a day after he was dismissed from a firm controlled by
Vaxcyte asks chairman Slaoui to resign after GSK harassment allegation
#vaxcyte
#slaoui
#gsk
3 years ago By DavidElliott — U.S. vaccine developer Vaxcyte Inc on Thursday asked board chairman Moncef Slaoui to step down, a day after GlaxoSmithKline dismissed him as an independent
GSK says Moncef Slaoui dismissed as Galvani chairman
#gsk
#moncefslaoui
#galvani
3 years ago By Tife — Glaxosmithkline said that Moncef Slaoui has been dismissed as chairman of Galvani Bioelectronics, which is majority owned by GSK.
GSK sees lower profit this year, split plans on track
#gsk
#news
3 years ago By Gabriel — Britain's GSK forecast a dip in earnings this year as it grapples with COVID-19 disruptions and invests in its pipeline of new drugs, and said its plans to
GSK says split plans on track, forecasts dip in profit this year
#gsk
#news
3 years ago By Omosebi — Britain's GSK said on Wednesday its plan to split into two businesses was on track, as the drugmaker aiding in COVID-19 vaccine developments forecast 2021